News 2017

  • Plasticell signs stem cell research collaborations with leading Singap

    28 March 2017

    28 March 2017, Stevenage UK: Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stemcell... read more



  • LIfT BioSciences Wins Medcity Award

    23 March 2017

    LIfT BioSciences has been announced as one of the winners of Medcity’s Collaborate to Innovate Award and grant. The focus for the project work with Professor Farzin Farzaneh, Professor of Molecular Medicine at King’s College London, is to develop in-vitro evidence that LIfT... read more



  • Fisher BioServices’ CryoHub to co-locate with manufacturing centre

    21 March 2017

    Fisher BioServices’ CryoHub to co-locate with the Cell and Gene Therapy Catapult manufacturing centre for seamless supply chain management and to accelerate cell and gene therapy production. London, 21 March 2017 – To help address the challenges surrounding supply chain... read more



  • Autifony Therapeutics obtains £1.3 million in funding from Innovate UK

    15 March 2017

    Stevenage, UK - 15th March 2017 - Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous system, today announced a new funding award of £895,000 from the Biomedical... read more



  • STEVENAGE BIOSCIENCE CATALYST'S CEO MARTINO PICARDO TO LEAVE AT THE EN

    13 March 2017

    Stevenage, UK, March 14 2017 – Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, has announced that CEO Martino Picardo will be leaving at the end of June. Dr Picardo, SBC's first CEO, will return to his home base in Manchester... read more



  • East of England Science and Innovation Audit - Life Sciences Theme

    10 March 2017

    Report from kick-off meeting at Innovate UK East of England conference, February 21 The Life Sciences theme of the East of England Science and Innovation Audit has made substantial progress. We are continuing to seek views 1 from many of the key organisations in life sciences across the... read more



  • Apollo Therapeutics: Funding of Four Initial Projects and Operational

    22 February 2017

    First four drug discovery programmes now launched in collaboration with academics at all three partner universities - spanning a variety of disease areas and drug modalities Recruited highly experienced Project Directors with track records of delivering project success within big pharma ... read more



  • Clinical trial for new innovative Osteoarthritis drug

    16 February 2017

    The University of Liverpool, in partnership with AKL Research and Development Ltd , is to lead on a clinical trial to test a potential new drug treatment for osteoarthritis. Osteoarthritis (OA) is the most common type of arthritis inthe UK, affecting more than eight million people*, and is the... read more



  • Cancer Research Technology, UCL, and Tusk Therapeutics join forces to

    7 February 2017

    ​London and Stevenage, United Kingdom | February 7, 2017 CANCER RESEARCH TECHNOLOGY, Cancer Research UK’s commercial arm, Tusk Therapeutics, an immuno-oncology company and UCL (University College London) have signed a licence and collaboration agreement to research, develop and... read more



  • Plasticell increases flow of stem cell therapy pipeline Plasticell

    7 February 2017

    Plasticell founder named “Best CEO in the Stem Cell industry” by European CEO magazine 07January 2017, Stevenage UK: Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that the Company’s founder, Dr. Yen Choo, has been named... read more



  • SBC & East and North Hertfordshire NHS Trust launch clinical expertise

    6 February 2017

    Trust staff to provide clinical guidance to tenants & across SBC network Stevenage, UK, February 6 2017 – Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, and the East and North Hertfordshire NHS Trust are pleased to... read more



  • LIfT BioSciences Joins Stevenage Bioscience Catalyst

    6 February 2017

    LIfT BioSciences has joined the UK's leading BioIncubator, Stevenage Bioscience Catalyst (SBC), for the UK's most promising SMEs in the healthcare space. The move will give LIfT Bio access to a spectrum of state-of-the-art translational research labs and development capabilities, including... read more



  • Stevenage Bioscience Catalyst is five years old

    1 February 2017

    Great start to sixth year as money raised by tenants exceeds £200m Stevenage, UK, February 1 2017 – Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, is celebrating its fifth birthday. Opened in February 2012 to bring... read more



  • Ossianix receives milestone payment from Lundbeck for blood-brain barr

    26 January 2017

    Shark antibody technology has potential to deliver therapeutics across previously impermeable BBB 26 January 2017 - PHILADELPHIA, USA & STEVENAGE, UK: Ossianix Inc., which has generated a world leading platform for delivering biotherapeutic products into the CNS using the highly versatile... read more



  • East of England Science and Innovation Audit - Life Sciences Theme

    18 January 2017

    Commissioned by the Department of Business, Energy and Industrial Strategy (BEIS), Science and Innovation Audits ( SIAs ) are taking place across the UK. Their aims include pinpointing of areas of global competitive advantage, informing future science and innovation strategy, and the generation of... read more



  • Autifony Therapeutics announces positive results from Phase I study of

    10 January 2017

    Demonstrated dose dependent changes in Mismatch Negativity latency in healthy volunteers; Phase Ib Ketamine challenge study initiated in Manchester London, UK -10th January 2017 - Autifony Therapeutics Limited (“Autifony”),which ispioneering the development of novel... read more



  • NeRRe Therapeutics raises £23million in oversubscribed Series B financi

    5 January 2017

    NeRRe Therapeutics raises £23 million in oversubscribed Series B financing round New funds to advance unique neurokinin receptor antagonist pipeline towards late-stage clinical development in common, chronicand debilitating respiratory and women’s health conditions. New... read more



  • Achilles Therapeutics starts 2017 with move to StevenageBioscience Cat

    Achilles Therapeutics starts 2017 with move to StevenageBioscience Cat

    4 January 2017

    Stevenage, UK, January 4 2017 – Achilles Therapeutics, which is focused on the development of novel cancer immunotherapies targeting neoantigens, has moved into its new headquarters at Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve... read more










 



Stevenage Bioscience Catalyst is UCL's Business Partner of the Year

Watch: 

Stevenage Bioscience Catalyst is UCL's Business Partner of the Year 2015

Funding Partners: